Gronwald et al. [84] completed a case control study looking at BRCA1- and BRCA2-mutation carriers who developed bilateral breast cancer (n = 285) versus those who had unilateral breast cancer (n = 781). The gene discussed is BRCA1; the disease is breast carcinoma.